Find a Conference

Alert - GRC systems are offline for approximately one week. For more information, please click here.

Atherosclerosis (GRS)

Gordon Research Seminar

Immunometabolic, Genetic and Molecular Mechanisms of Atherosclerosis

June 17 - 18, 2023
Chairs and
Rey Don Jaime Grand Hotel
Avinguda de l'Hotel
Castelldefels, Barcelona, Spain
 Venue and Travel Information

Conference Description

The Atherosclerosis GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators.

This meeting will focus on recent advances and emerging techniques in atherosclerosis research, including immunometabolism, lipid metabolism, systems biological approaches, transcriptomics and genetic factors, and how these findings in atherosclerosis research may be leveraged for therapeutic application. Claudia Kemper will give a scientific keynote lecture.

Related Meeting

This GRS will be held in conjunction with the "Atherosclerosis" Gordon Research Conference (GRC). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information.

Conference Program

Saturday
1:00 pm - 5:00 pm
Arrival and Check-in
3:00 pm - 3:15 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
3:15 pm - 4:00 pm
Keynote Session: A Fresh Perspective on Atherosclerosis - The Role of Complement
Discussion Leader:
3:15 pm - 3:25 pm
General Discussion
3:25 pm - 3:50 pm
"Complement and Complosome - An Old Dog Still Bites"
3:50 pm - 4:00 pm
Discussion
4:00 pm - 5:30 pm
Poster Session
5:30 pm - 7:30 pm
Molecular Mechanisms of Cardiometabolic Disease
Discussion Leaders: and
5:30 pm - 5:45 pm
"Molecular Alterations of Human Diabetic Heart Disease Revealed using Single Nucleus Sequencing"
5:45 pm - 5:50 pm
Discussion
5:50 pm - 6:05 pm
"Exploring How Cardiometabolic Disease Impacts the Immune Cell Lipidome"
6:05 pm - 6:10 pm
Discussion
6:10 pm - 6:25 pm
"Coronary Culprit Plaque Morphology Determines Residual Inflammatory Risk and Outcome – Novel Aspects Towards Precision Prevention Following Acute Coronary Syndrome"
6:25 pm - 6:30 pm
Discussion
6:30 pm - 6:45 pm
"Rac1 and NF-kB Signaling Regulate Macrophage Expression of IL-1ß and Atherosclerotic Calcification: Implications for Targeted Therapies"
6:45 pm - 6:50 pm
Discussion
6:50 pm - 7:05 pm
"IL1RAP Blockade Limits Development of Atherosclerosis and Reduces Plaque Inflammation"
7:05 pm - 7:10 pm
Discussion
7:10 pm - 7:25 pm
"FFAR4 Regulates Macrophage Metabolism and Foam Cell Formation"
7:25 pm - 7:30 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Sunday
7:30 am - 8:30 am
Breakfast
9:00 am - 11:00 am
Cells of the Vessel Wall and Metabolic Determinants of Cardiovascular Disease
Discussion Leaders: and
9:00 am - 9:15 am
"Recruited and Resident Cardiac Macrophage Phenotypes Converge in the Healing Infarct but not in the Failing Heart Exposed to Continuous Pressure Overload"
9:15 am - 9:20 am
Discussion
9:20 am - 9:35 am
"The Matrix Metalloproteinase ADAMTS7 Increases Foam Cell Formation and Atherosclerosis"
9:35 am - 9:40 am
Discussion
9:40 am - 9:55 am
"Endothelial Cells Communicate with Surrounding Vascular Cells via Bidirectional and Polarized Secretion of Extracellular Vesicular Cargo: Implications for Atherosclerotic Plaque Development"
9:55 am - 10:00 am
Discussion
10:00 am - 10:15 am
"The Cardiometabolic Disease Risk Protein SVEP1 Signals Through the Orphan Receptor PEAR1"
10:15 am - 10:20 am
Discussion
10:20 am - 10:35 am
"EZH2 Inhibition Reduces Macrophage Inflammatory Responses in Atherosclerosis"
10:35 am - 10:40 am
Discussion
10:40 am - 10:55 am
"Macrophage Heterogeneity in Metabolic Disease"
10:55 am - 11:00 am
Discussion
11:00 am - 12:30 pm
Poster Session
Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pm - 1:30 pm
Lunch
1:30 pm - 2:30 pm
Mentorship Component: Insights Into Successfully Obtaining Grants
Discussion Leader:
1:30 pm - 1:55 pm
"Navigating the NIH Career Development Awards"
1:55 pm - 2:00 pm
Discussion
2:00 pm - 2:25 pm
"High Dietary Salt Promotes a TH17 Cell Driven Gut-Bone Axis to Regulate Haematopoiesis and Atherosclerosis"
2:25 pm - 2:30 pm
Discussion
2:30 pm - 3:00 pm
Evaluation Period
Complete the GRS Evaluation Forms; Election of Future Chair(s)
3:00 pm
Seminar Concludes

Contributors

Gordon Research Conferences
National Institutes of Health - National Heart, Lung and Blood Institute (NHLBI)
Pfizer, Inc.
Ionis Pharmaceuticals

Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R13HL168781. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conference Links

Conference History Atherosclerosis
Additional Fee Info

Atherosclerosis
June 22 - 27, 2025


Contact Us

MyGRC Account
Check your application status, complete your registration, update your poster, change your rooming preference, make a bus reservation, print an invitation letter, print a receipt (which includes verification that you are presenting a poster) or print an invoice by logging into your account.

GRC Venues
Everything you need to know, to plan your trip.

FAQs
Instant answers to common questions.

Tell us how we can help

Call us and leave a detailed message at: 401-783-4011

*This voicemail is only checked once daily. Due to high volume of requests during the conference season, responses may be delayed.

You have no notifications